Fentanyl Sales Data
| Rank 91 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows fentanyl U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 91 ( 6) |
$189,255 | -2.58% | 4,078 | -6.62% |
| Q4 2012 | 85 (3) |
$194,261 | -1.28% | 4,367 | 8.09% |
| Q3 2012 | 82 (4) |
$196,777 | -0.39% | 4,040 | 0.67% |
| Q2 2012 | 78 ( 5) |
$197,539 | 0.10% | 4,013 | 7.36% |
| Q1 2012 | 83 (4) |
$197,350 | -3.34% | 3,738 | -11.90% |
| Q4 2011 | 79 (5) |
$204,161 | -2.90% | 4,243 | -4.76% |
| Q3 2011 | 74 (1) |
$210,250 | -2.89% | 4,455 | -2.50% |
| Q2 2011 | 73 (5) |
$216,512 | -0.62% | 4,569 | 4.58% |
| Q1 2011 | 78 | $217,863 |  |
4,369 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
